China has given regulatory nod to the Phase 1 study of the intranasal spray vaccine against the novel coronavirus, Express Pharma has reported.

The vaccine is being co-developed by Beijing Wantai Biological Pharmacy Enterprise and researchers from Xiamen University and Hong Kong University.

The vaccine received authorisation from the China National Medical Products Administration.

Also read: Biotechs move toward first US Covid-19 vaccinations by year-end

According to the report, the vaccine could be feasible and effective, especially for mass distribution. It works on the same mechanism as the influenza vaccine.

The GlobalData drugs database revealed that currently, five intranasal vaccines for coronavirus are under development. All these vaccines contain SARS-CoV-2 spike protein in their formulations.

Scotty Chung-Siu, MPH, Senior Analyst at GlobalData, stated, as cited in the Express Pharma report: “Nasal sprays are far less invasive for the recipient than the intramuscular injection alternative, as the drug can be rapidly

Read More

Let’s start where we usually do on Mondays: last week’s fund flows from ETF.com:

The SPY had a huge outflow of $6.8 billion, more than reversing the inflows from the last two weeks. The IWM (Russell 2000) also lost a large amount of cash. But traders are buying the QQQ’s dip. Finally, there was a large move into the long-bond — a clear safety play.Tech was the big loser, losing $1.35 billion last week. It’s brethren communication services was more fortunate, only seeing a $145 billion outflow. Financials are also losing money. Investors are probably seeing a very poor 3Q20 on the horizon for the banking industry and acting accordingly. Interestingly, consumer staples and health care (two defensive sectors) also had a net outflow. Only four sectors saw inflows. Overall, this is a bearish table.

Is the recovery running out of steam? Last week, a chorus of Federal Reserve

Read More

KEY POINTS

  • The Warsaw government predicted photovoltaic power will dominate the country’s energy profile by 2040
  • Poland is now the fourth-biggest solar market in Europe
  • Poland agreed to shut down its coal mines by 2049

Poland, one of the world’s biggest producers and users of coal, has made a bold move to phase out fossil fuels and develop more renewables, especially solar energy.

Warsaw predicted photovoltaic power – the method by which solar cells convert energy from the sun to generate electric power — will dominate the country’s energy profile by 2040. By that point, Poland’s solar capacity – that is, the maximum output of electricity from solar power – is expected to surge to 16 gigawatts from 2.5 gigawatts currently.

(One gigawatt is equal to the energy generated by 3.125 million photovoltaic panels, according to the U.S. Department of Energy).

The Polish government also predicted that by 2040, coal

Read More


MILFORD — Businesses, outdoor venues, and indoor performing arts facilities throughout Milford are gearing up for Phase 3 of the state’s opening from the pandemic.

The details were announced by Gov. Ned Lamont, and will take effect Oct. 8. Phase 3 involves an increase from 50 percent to 75 percent capacity indoors – subject to COVID-19 safety requirements – for restaurants, personal services, hair salons, barber shops, and libraries. Additionally, outdoor event venues will increase from 25 percent to 50 percent capacity.

Bars and nightclubs will continue to remain closed.

Julie Nash, Milford’s

Read More

CONNECTICUT (WTNH) — With some 20% of state eateries gone for good, the Phase 3 reopening rollout will fix some wounds for restaurants and businesses, but not others.

“As long as we keep our masks on, keep the distance, keep the rules that they set, then we should be fine,” said Jasmine Sheppard, a customer at the always bustling Zoi’s in New Haven.

“As long as people are practicing social distancing, I don’t think there’s going to be a problem,” agreed fellow customer, Greg Morehead.

The governor’s easing of indoor capacity limits for restaurants and salons from 50% to 75% is coming right on time.

“With the cold weather, with the outdoor seating, we’re going to lose that, so the fact that we’re going to have more indoor seating, it’s going to be a plus for us,” said Stacey Kattis with Zoi’s.

Salons are also looking forward to the easing

Read More

Johnson & Johnson has initiated advanced, large-scale, multi-country trials on its single-shot Covid-19 vaccine candidate, JNJ-78436735, being developed by Janssen Pharmaceutical Companies.

The initiation of its Phase III ENSEMBLE trial follows positive interim results from J&J’s Phase 1/2a clinical study, which demonstrated safety and immunogenicity after a single vaccination, a note from J&J said. These results have been submitted and are due to be published in medRxiv.

Also read: Johnson & Johnson’s Covid-19 vaccine shows promise in hamsters

ENSEMBLE will enrol up to 60,000 volunteers across three continents and will study the safety and efficacy of a single vaccine dose versus placebo in preventing Covid-19. J&J has continued scaling-up its manufacturing capacity and remains on track to meet its goal of providing one billion doses of a vaccine each year, it said.

The company hoped to bring in an affordable vaccine on a not-for-profit basis for emergency pandemic use and

Read More

The commodities market was largely biased towards upside, the crude oil was the best performer last week. Since crude oil, the largest component, rallied sharply, the iCOMDEX, composite index of the Multi Commodity Exchange of India (MCX), was positive, posting a gain of 1.7 per cent.

The second-largest component, gold, was largely flat and continues to stay in the sideways trend.

MCX-Crude (₹3,017)

The October futures of crude oil on MCX, after beginning on a flat note last week, saw a sharp rally in price. The price has closed above the important level of ₹3,000.

However, the overall trend will be inclined to downside. Following the rally, the daily relative strength index (RSI) and the moving average convergence divergence (MACD) indicators on the daily chart, reversing higher.

By looking at the price action, traders can stay on the fence until either ₹3,000 or ₹3,160 is taken out. The direction of

Read More

Pfizer Inc. and BioNTech SE on Saturday announced that they are planning to expand the Phase 3 trials for their experimental Covid-19 vaccine.

The companies have submitted an amended protocol for their trials to the US Food and Drug Administration. They plan to enrol up to 44,000 participants in the expanded trials “which also allows for the enrollment of new populations.”

The companies are expecting the results of the trials to be out by October 2020.

“Based on current infection rates, the companies continue to expect that a conclusive readout on efficacy is likely by the end of October,” the companies said in a joint statement.

The enrollment trial is going as planned, expecting to meet its initial target of up to 30,000 participants next week.

“The proposed expansion would allow the companies to further increase trial population diversity, and include adolescents as young as 16 years of age and

Read More

SOMERVILLE, MA — Somerville will consider a limited reopening of fitness centers, gyms and indoor recreation facilities on approximately Sept. 8, Mayor Joseph Curtatone said this week. Opening is contingent on health data continuing to trend in the right direction.

The decision was made following a meeting with Phase 3 business owners on Monday. Businesses would be required to have an approved health and safety plan and meet stringent COVID-19 safety requirements, including some measures that exceed state standards.

The city will decide Monday whether the Sept. 8 opening date will move forward. Detailed guidelines will also be shared. Affected business owners are invited to attend a live online update on Monday, August 31, at 1 p.m., and information will be posted to the public as well on www.somervillema.gov/CovidBiz. Register for the online update here.

In Somerville, indoor and outdoor gathering capacity limits also remain at stricter levels than the

Read More

The latest progress in U.S.-China trade talks has brought optimism in markets. Ending speculations and concerns over simmering tensions between the two large economies, trade officials have reaffirmed their commitment to the Phase 1 trade deal. Notably, the pledge was made between US Trade Representative Robert Lighthizer, US Treasury Secretary Steven Mnuchin and Chinese Vice Premier Liu He on a phone call, which was previously expected on Aug 15.

In this regard, US Trade Representative’s office (USTR) said that, “both sides see progress and are committed to taking the steps necessary to ensure the success of the agreement,” per a Reuters article. It also mentioned that “the parties also discussed the significant increases in purchases of US products by China as well as future actions needed to implement the agreement.” Discussions were also done on China’s actions to enhance the protection of U.S. intellectual property, regulate the forced transfer of

Read More